INTEGRIN B1; RBX-100UL

Code: AB1952 D2-231

Analysis Note

ControlU251 cell line

Application

Research Sub CategoryIntegrins

Anti-Integrin beta1 Antibody, Cytosolic detects level of Int...


 Read more

Your Price
€468.00 EACH
€575.64 inc. VAT

Analysis Note

ControlU251 cell line

Application

Research Sub CategoryIntegrins

Anti-Integrin beta1 Antibody, Cytosolic detects level of Integrin beta1 & has been published & validated for use in IP & WB.

Research CategoryCell Structure

Immunoprecipitation:
1 µL of antiserum per 25 µg total cell protein (in 40 µL). ) 0.5% triton X-100 lysis buffer with proteinase inhibitors is suggested.

Optimal working dilutions must be determined by end user.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Integrin beta 1, also known as CD29, is a 130 kDa transmembrane glycoprotein that forms noncovalent complexes with various Integrin alpha subunits (including alpha 1, alpha 2, alpha 3, alpha 4, alpha 5, and alpha 6) to form the functional receptors that bind to specific extracellular matrix proteins. Integrin receptors are involved in the regulation of a variety of important biological functions, including embryonic development, wound repair, hemostasis, and prevention of programmed cell death. They are also implicated in abnormal pathological states such as tumor directed angiogenesis, tumor cell growth, and metastasis. These heterodimeric receptors bridge the cytoplasmic actin cytoskeleton with proteins present in the extracellular matrix and/or on adjacent cells. Interactions between integrins and the extracellular matrix lead to activation of signal transduction pathways and regulation of gene expression.

Immunogen

Epitope: C-terminus

Synthetic peptide corresponding to the c-terminal cytoplasmic domain of human β-1 integrin.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Physical form

Rabbit polyclonal serum containing no preservatives

Unpurified

Quality

Western Blot Analysis:
1:500 to 1:1000 dilution of this antibody was used for detection of integrin beta1 in whole cell lysate under non-reducing. Size of beta 1 integrin under non-reduced conditions is approximately 110 kDa; often a 220 kDa dimer is observed as well; beta -1 under reduced conditions runs as a 130kDa band with higher molecular weight aggregates as well.

Specificity

Reactive with human, mouse and rat integrin β-1, as confirmed by western blot. Not reactive with other integrins.

Storage and Stability

Stable for 1 year at -20°C from date of receipt.

Target description

~130 kDa

antibody formserum
antibody product typeprimary antibodies
biological sourcerabbit
clonepolyclonal
Gene Informationhuman ... ITGB1(3688)
manufacturer/tradenameChemicon®
NCBI accession no.NM_002211.2
Quality Level100
shipped indry ice
species reactivityrat, human, mouse, pig
technique(s)western blot: suitable, immunoprecipitation (IP): suitable
UniProt accession no.P05556
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.